Menu

ABSTRACTS

PP17 Targeting of the histone methyltransferases G9a and GLP in multiple myeloma

BJH - volume 10, issue Abstract Book BHS, february 2019

No authors

Read more

PP33 miR-15a-5p and miR-21-5p contribute to chemoresistance in acute myeloid leukemia by targeting PDCD4, ARL2 and BTG2

BJH - volume 10, issue Abstract Book BHS, february 2019

No authors

Read more

PP34 Chromosomal aberrations in chronic myeloid leukemia: response to conventional tyrosine kinase inhibitors and risk of blastic transformation

BJH - volume 10, issue Abstract Book BHS, february 2019

No authors

Read more

PP35 Efficacy and safety of ponatinib in chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) patients in real-world clinical practice: data from a Belgian registry

BJH - volume 10, issue Abstract Book BHS, february 2019

No authors

Read more

PP36 In vitro generation of tumor antigen-specific T-cells from healthy donor and patient stem cells

BJH - volume 10, issue Abstract Book BHS, february 2019

No authors

Read more

PP37 In vitro investigations of the effect of BCR-ABL tyrosine kinase inhibitors on endothelial cell viability

BJH - volume 10, issue Abstract Book BHS, february 2019

No authors

Read more

PP49 Ravulizumab* (ALXN1210) vs eculizumab in complement inhibitor-naive adult patients with PNH

BJH - volume 10, issue Abstract Book BHS, february 2019

No authors

Read more
Top